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2-EAL Pharmacological and
physiological studies of Ca2+ channels on
the basis of their molecular entities
Yasuo Mori
Dept. Synthetic Chem. Biol. Chem., Grad. Sch. Engineer, Kyoto Univ. Grad. Sch.
Global Enviornment. Studies, Kyoto Univ.
Translocation of inorganic ions across the biomembrane is
among the most important physical chemical bases of biologi-
cal phenomena. Among various inorganic substances, Ca2+ is
the only second messenger, which renders Ca2+ influx into the
cell through Ca2+ permeable ion channels central to pharma-
cology and physiology. Recently, the fusion of these academic
fields with molecular biology has led to the discoveries of mo-
lecular entities of Ca2+ permeable channels that are function-
ally novel. Also, their functional features have revealed new
cellular and organ functions, inspiring traditional pharmacol-
ogy and physiology with spirit of post genome era, when the
entire nucleotide sequence of human genome is already deter-
mined. Here, I would like to discuss on this issue by mainly
focusing on my research subjects, the P/Q type voltage de-
pendent channel essential for neurotransmitter release and
redox sensitive TRP Ca2+ permeable channels.
2-YAL-02 Exploring the mechanisms of
kidney injury and the strategy for the
treatment
Daisuke Nakano
Dept. Pharmacol., Kagawa Univ. Sch. Med
Renal parenchyma composed by more than ten kinds of cells.
Previous studies have been unveiling the black box of kidney
diseases. Nonetheless, there are a limited number of drugs
available to treat either chronic kidney disease or acute kid-
ney injury. Our idea is to simplify the complicated renal dis-
ease by intravital imaging using multiphoton microscopy.
The intravital imaging of the kidney revealed the unknown
renal (patho) physiology, such as the relationship between the
glomerular permeability of multiple proteins in the glomer-
uli and the urinary excretion of these proteins in chronic kid-
ney disease animals, morphological changes accompanying by
a phenotype change in renal erythropoietin producing cells,
and the mechanism of oliguria in the septic acute kidney in-
jury. We are also evaluating how the potential therapeutic
strategies against kidney disease work in the kidney, par-
tially by using the above written technique, and our goal is to
transfer the findings to the bench.S2-YAL-01 Translational Research to
develop a novel medical therapy against
intracranial aneurysm
Tomohiro Aoki
Innovation Center for Immunoregulation Technology and Therapeutics, Kyoto
Univ. Sch. Med.
Intracranial aneurysm (IA) is a major cause of subarachnoid
hemorrhage which has a mortality rate of 50%. Given the sus-
ceptibility to such a fatal illness, treatment of IA to prevent
rupture is important for the society. Nevertheless, there is no
medical therapy available for IA because how IA develops or
progresses remains unclear. Thus, to develop a novel medical
therapy, we have examined mechanisms underlying IA for-
mation and progression mainly using animal models and re-
vealed some important issues. From studies including ours,
currently, IA is defined as the chronic inflammatory disease,
like other important diseases such as cancer and atheroscle-
rosis, in intracranial arteries triggered by hemodynamic
force loaded on arterial bifurcations where IA is formed. In
this process, macrophage infiltration in arterial walls and
subsequent macrophage mediated inflammatory response is
crucial. As one of the critical factors mediating inflammatory
responses leading to IA, we have identified ProstaglandinE2
EP2 NF κB cascade. In addition, through animal and also
clinical studies, we have clarified the potential of anti inflam-
matory drugs as therapeutic ones to prevent the progression
and rupture of IAs and indicated, first in the world, that IA
can be treated by medical therapy.
2-YAL-03 A novel method for
dissecting neural circuits with
glycoprotein deleted rabies virus
vectors
Fumitaka Osakada
Lab. Cell. Pharmacol., Grad. Sch. Pharm. Sci., Nagoya Univ. Lab. Neural
Information Processing, Inst. Adv. Res., Nagoya Univ. PREST, JST
Neural circuits in the brain operate over a vast range of spa-
tiotemporal and computational scales, from high level cir-
cuits that integrate information across multiple brain re-
gions, to microcircuits that perform simple input/output
transformations within a specialized brain structure. Deci-
phering how neural circuits within the mammalian brain
give rise to perception, cognition, and behavior is central to
understanding how the nervous system functions and what
are the causes of neurological disorders. Considerable effort
has been devoted to revealing brain circuits. Such studies are
most useful when they also allow links to be made to function,
by correlating activity with circuits and by manipulating cir-
cuit components and monitoring changes in function or be-
havior. To this end, I have been developing a transsynaptic
tracing system using rabies virus vectors for the dissection
of circuit structure and function in the normal and diseased
brain. Combining these tools with modern in vivo imaging
and optogenetic/pharmacogenetic methods will allow previ-
ously unimaginable experiments investigating neural circuit
development, plasticity, and function.6
